Form 4 for GPCR Structure Therapeutics Inc.
Accepted 2023-02-09 00:00:00 ET · period of report 2023-02-07 · accession 0000318989-23-000054 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2023-02-09 | 2023-02-07 | GPCR | FIL Ltd | See Remark 1 | C - Cnv Deriv | — | +6.47M | 494.0K | New | — |
| DMI | 2023-02-09 | 2023-02-07 | GPCR | FIL Ltd | See Remark 1 | C - Cnv Deriv | — | -6.47M | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-02-07 | C | A | 4,013,678 | — | 4,013,678 | I Eight Roads Investments | — | — | (F1) On February 7, 2023, in connection with the completion of the issuer's initial public offering, each share of Series A, A+, B, and B-1 Preferred Shares converted on a 1-for-1 basis into Ordinary Shares. |
| 2 | Common | Ordinary Shares | 2023-02-07 | C | A | 620,499 | — | 4,634,177 | I Eight Roads Investments | — | — | (F1) On February 7, 2023, in connection with the completion of the issuer's initial public offering, each share of Series A, A+, B, and B-1 Preferred Shares converted on a 1-for-1 basis into Ordinary Shares. |
| 3 | Common | Ordinary Shares | 2023-02-07 | C | A | 179,242 | — | 5,266,286 | I Eight Roads Investments | — | — | (F1) On February 7, 2023, in connection with the completion of the issuer's initial public offering, each share of Series A, A+, B, and B-1 Preferred Shares converted on a 1-for-1 basis into Ordinary Shares. |
| 4 | Common | Ordinary Shares | 2023-02-07 | C | A | 71,636 | — | 71,636 | I ERVC Healthcare Advisors IV, LP | — | — | (F1) On February 7, 2023, in connection with the completion of the issuer's initial public offering, each share of Series A, A+, B, and B-1 Preferred Shares converted on a 1-for-1 basis into Ordinary Shares. |
| 5 | Common | Ordinary Shares | 2023-02-07 | C | A | 10,154 | — | 81,790 | I ERVC Healthcare Advisors IV, LP | — | — | (F1) On February 7, 2023, in connection with the completion of the issuer's initial public offering, each share of Series A, A+, B, and B-1 Preferred Shares converted on a 1-for-1 basis into Ordinary Shares. |
| 6 | Common | Ordinary Shares | 2023-02-07 | C | A | 7,411 | — | 89,201 | I ERVC Healthcare Advisors IV, LP | — | — | (F1) On February 7, 2023, in connection with the completion of the issuer's initial public offering, each share of Series A, A+, B, and B-1 Preferred Shares converted on a 1-for-1 basis into Ordinary Shares. |
| 7 | Common | Ordinary Shares | 2023-02-07 | C | A | 452,867 | — | 5,087,044 | I Eight Roads Investments | — | — | (F1) On February 7, 2023, in connection with the completion of the issuer's initial public offering, each share of Series A, A+, B, and B-1 Preferred Shares converted on a 1-for-1 basis into Ordinary Shares. |
| 8 | Common | Ordinary Shares | 2023-02-07 | C | A | 624,239 | — | 624,239 | I ERVC Healthcare IV, LP | — | — | (F1) On February 7, 2023, in connection with the completion of the issuer's initial public offering, each share of Series A, A+, B, and B-1 Preferred Shares converted on a 1-for-1 basis into Ordinary Shares. |
| 9 | Common | Ordinary Shares | 2023-02-07 | C | A | 494,035 | — | 494,035 | I ERVC Healthcare V, LP | — | — | (F1) On February 7, 2023, in connection with the completion of the issuer's initial public offering, each share of Series A, A+, B, and B-1 Preferred Shares converted on a 1-for-1 basis into Ordinary Shares. |
| 10 | Derivative | Series A Convertible Preferred Shares | 2023-02-07 | C | D | 624,239 | — | 0 | I ERVC Healthcare IV, LP | — · — to — | 624,239 Ordinary Shares | (F1) On February 7, 2023, in connection with the completion of the issuer's initial public offering, each share of Series A, A+, B, and B-1 Preferred Shares converted on a 1-for-1 basis into Ordinary Shares. |
| 11 | Derivative | Series B-1 Convertible Preferred Shares | 2023-02-07 | C | D | 494,035 | — | 0 | I ERVC Healthcare V, LP | — · — to — | 494,035 Ordinary Shares | (F1) On February 7, 2023, in connection with the completion of the issuer's initial public offering, each share of Series A, A+, B, and B-1 Preferred Shares converted on a 1-for-1 basis into Ordinary Shares. |
| 12 | Derivative | Series B Convertible Preferred Shares | 2023-02-07 | C | D | 7,411 | — | 0 | I ERVC Healthcare Advisors IV, LP | — · — to — | 7,411 Ordinary Shares | (F1) On February 7, 2023, in connection with the completion of the issuer's initial public offering, each share of Series A, A+, B, and B-1 Preferred Shares converted on a 1-for-1 basis into Ordinary Shares. |
| 13 | Derivative | Series A+ Convertible Preferred Shares | 2023-02-07 | C | D | 10,154 | — | 0 | I ERVC Healthcare Advisors IV, LP | — · — to — | 10,154 Ordinary Shares | (F1) On February 7, 2023, in connection with the completion of the issuer's initial public offering, each share of Series A, A+, B, and B-1 Preferred Shares converted on a 1-for-1 basis into Ordinary Shares. |
| 14 | Derivative | Series A Convertible Preferred Shares | 2023-02-07 | C | D | 71,636 | — | 0 | I ERVC Healthcare Advisors IV, LP | — · — to — | 71,636 Ordinary Shares | (F1) On February 7, 2023, in connection with the completion of the issuer's initial public offering, each share of Series A, A+, B, and B-1 Preferred Shares converted on a 1-for-1 basis into Ordinary Shares. |
| 15 | Derivative | Series B-1 Convertible Preferred Shares | 2023-02-07 | C | D | 179,242 | — | 0 | I Eight Roads Investments | — · — to — | 179,242 Ordinary Shares | (F1) On February 7, 2023, in connection with the completion of the issuer's initial public offering, each share of Series A, A+, B, and B-1 Preferred Shares converted on a 1-for-1 basis into Ordinary Shares. |
| 16 | Derivative | Series B Convertible Preferred Shares | 2023-02-07 | C | D | 452,867 | — | 0 | I Eight Roads Investments | — · — to — | 452,867 Ordinary Shares | (F1) On February 7, 2023, in connection with the completion of the issuer's initial public offering, each share of Series A, A+, B, and B-1 Preferred Shares converted on a 1-for-1 basis into Ordinary Shares. |
| 17 | Derivative | Series A+ Convertible Preferred Shares | 2023-02-07 | C | D | 620,499 | — | 0 | I Eight Roads Investments | — · — to — | 620,499 Ordinary Shares | (F1) On February 7, 2023, in connection with the completion of the issuer's initial public offering, each share of Series A, A+, B, and B-1 Preferred Shares converted on a 1-for-1 basis into Ordinary Shares. |
| 18 | Derivative | Series A Convertible Preferred Shares | 2023-02-07 | C | D | 4,013,678 | — | 0 | I Eight Roads Investments | — · — to — | 4,013,678 Ordinary Shares | (F1) On February 7, 2023, in connection with the completion of the issuer's initial public offering, each share of Series A, A+, B, and B-1 Preferred Shares converted on a 1-for-1 basis into Ordinary Shares. |